Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yohimbine Hydrochloride for Social Phobia
NCT00958880Phase 3Completed
- Sponsor
- Southern Methodist University
- Start
- Mar 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of yohimbine in Social Anxiety Disorder (SAD), sponsored by Southern Methodist University. Started Mar 2009; status: completed.
02
Drugs
yohimbine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00958880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958880.